Pii has established a global reach through its locations in the US and Europe

Join our Mailing List

Your Email


Pii has over 430,000 sq. feet of product development laboratory and cGMP manufacturing space. From prototype development to commercial launch, Pii's quality designed facilities are integrated to ensure development milestones are met on time and on budget.

Headquartered in Hunt Valley, Maryland, Pii’s facilities are custom designed and include formulation, analytical laboratories, and cGMP manufacturing suites. With our broad range of experience and deep expertise, we have the talent and technologies to help bring your drug candidate from idea to market.  This is backed by over 430,000 square feet of development and manufacturing space, with facilities located in the US and Europe.

Pii’s state-of-the-art facilities consist of over 70 production rooms, including manufacturing and containment suites, dedicated soft gel suites, a formulation development center, and analytical laboratories as well as a development and manufacturing site in the UK. Facilities have been inspected by the FDA and EMA and are registered with the DEA for Schedules I-V. In the UK, Pii has over 45,000 square feet of MHRA-approved cGMP facility space dedicated to Phase I and II manufacturing; solid state screening and oral and inhaled drug delivery development.


North America

  Pii Corporate Headquarters
10947 Golden West Drive, Hunt Valley, MD 21031 USAPhone: +1 410 584 0001
Fax+1 410 527 0525


10819 Gilroy Road, Hunt Valley, MD 21031 USA

  • HME, softgel and liquid product development and manufacturing
  • Commercial Manufacturing of non-sterile dosage forms
  • QC Testing


Beaver Court
103 Beaver Court, Hunt Valley, MD 21030 USA

  • Solid oral product development and CTM Manufacturing
  • Sterile product development and CTM & Commercial Manufacturing


Facilities Beaver Dam
10950 Beaver Dam Road, Hunt Valley, MD 21031 USA

  • Analytical Methods Development



  Pharmaterials – A division of Pii
Unit B,  5, Boulton Road,  Reading, RG2 0NH United Kingdom
Phone +44 (0) 1189 209900
Fax+44 (0) 1189 310679

  • Solid State Screening
  • Phase I and II oral product development and manufacturing
  • Inhaled product development and manufacturing
  • QP Services

© Copyright 2017 Pharmaceutics International, Inc. | Privacy Policy | Terms & Conditions